Isoflavone Treatment for Postmenopausal Osteopenia.
Condition(s):Osteopenia; OsteoporosisLast Updated:December 4, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Osteopenia; OsteoporosisLast Updated:December 4, 2023Completed
Condition(s):Hormone Refractory Prostate CancerLast Updated:August 5, 2014Unknown status
Condition(s):Safety; Tolerability; Pharmacokinetics; CancerLast Updated:May 23, 2016Completed
Condition(s):Corneal Graft RejectionLast Updated:August 1, 2014Unknown status
Condition(s):Multiple MyelomaLast Updated:August 2, 2018Completed
Condition(s):Multiple MyelomaLast Updated:October 31, 2023Completed
Condition(s):Bell’s PalsyLast Updated:June 4, 2008Completed
Condition(s):Multiple MyelomaLast Updated:July 3, 2023Completed
Condition(s):MULTIPLE MYELOMA (MM)Last Updated:November 30, 2023Active, not recruiting
Condition(s):Birdshot Chorioretinopathy; Cystoid Macular Edema; Transient Partial Visual LossLast Updated:January 23, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.